Medifast Inc's Suppliers recorded an increase in sales by 11.02 % year on year in Q2 2026, sequentially sales grew by 14.46 %, Medifast Inc's cost of sales deteriorated by -17.9 % year on year, relative to one quarter ago cost of sales fell by -4.22 % in Q2.
Medifast Inc's Suppliers recorded an increase in sales by 11.02 % year on year in Q2 2026, sequentially sales grew by 14.46 %, Medifast Inc's cost of sales deteriorated by -17.9 % year on year, compare to one quarter ago cost of sales fell by -4.22 % in Q2.
Jason Pharmaceuticals, Inc., the Company’s wholly-owned subsidiary, manufactures
and produces all Medifast powder-based products, which is approximately 42% of
Medifast’s product revenues, in the manufacturing facility in Owings Mills,
Maryland. The Company purchased the plant in July 2002 and has gradually increased
production capacity and improved overall efficiencies with additional investments
in blending and packaging equipment. The remaining 58% of Medifast products are
manufactured by third party vendors in accordance with Medifast proprietary formulas
and manufacturing standards. Our Owings Mills manufacturing facility is regulated
and inspected by the United States Food and Drug Administration (“FDA”),
the United States Department of Agriculture (“USDA”) and the Maryland
State Department of Health and Mental Hygiene. It is certified as a Safe Quality
Food Program (SQF) Level 2 facility compliant with the Global Food Safety Initiative.
Medifast Inc's Comment on Supply Chain
Jason Pharmaceuticals, Inc., the Company’s wholly-owned subsidiary, manufactures
and produces all Medifast powder-based products, which is approximately 42% of
Medifast’s product revenues, in the manufacturing facility in Owings Mills,
Maryland. The Company purchased the plant in July 2002 and has gradually increased
production capacity and improved overall efficiencies with additional investments
in blending and packaging equipment. The remaining 58% of Medifast products are
manufactured by third party vendors in accordance with Medifast proprietary formulas
and manufacturing standards. Our Owings Mills manufacturing facility is regulated
and inspected by the United States Food and Drug Administration (“FDA”),
the United States Department of Agriculture (“USDA”) and the Maryland
State Department of Health and Mental Hygiene. It is certified as a Safe Quality
Food Program (SQF) Level 2 facility compliant with the Global Food Safety Initiative.
MED's Suppliers Net Income grew by
MED's Suppliers Net margin grew in Q2 to
12.28 %
5.98 %
MED's Suppliers Net Income grew by 12.28 %
MED's Suppliers Net margin grew in Q2 to 5.98 %
Medifast Inc's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Medifast Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Medifast Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
14.62 %